Advancements in XPro1595 and AI Biosensor for Neurodegenerative Disease Detection

INmune Bio's experimental therapy XPro1595 has shown potential in promoting myelin restoration by activating microglia and astrocytes, contrary to the belief that reduced activation of these glial cells is necessary for nervous system repair. The therapy, which selectively blocks a form of tumor necrosis factor (TNF), has demonstrated remyelinating effects in a mouse model of myelin loss. The findings may lead to novel treatment strategies for multiple sclerosis and other neurodegenerative disorders.